ReCode Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- ReCode Therapeutics's estimated annual revenue is currently $22.2M per year.
- ReCode Therapeutics's estimated revenue per employee is $155,000
- ReCode Therapeutics's total funding is $357M.
Employee Data
- ReCode Therapeutics has 143 Employees.
- ReCode Therapeutics grew their employee count by -4% last year.
ReCode Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Senior Management Associate, supporting the CEO | Reveal Email/Phone |
3 | President & CEO | Reveal Email/Phone |
4 | VP, Program Management, Head PMO | Reveal Email/Phone |
5 | VP, Corporate Controller | Reveal Email/Phone |
6 | VP People | Reveal Email/Phone |
7 | SVP Clinical Development | Reveal Email/Phone |
8 | SVP, Legal Affairs & Business Operations | Reveal Email/Phone |
9 | SVP, Research | Reveal Email/Phone |
10 | SVP, CMC | Reveal Email/Phone |
ReCode Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is ReCode Therapeutics?
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. The Company's diverse pipeline includes lead programs for cystic fibrosis (CF) caused by nonsense mutations, and primary ciliary dyskinesia (PCD). ReCode has developed a non-viral delivery therapeutic platform that enables it to precisely deliver its medicines safely and effectively. The Company is leveraging its lipid nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. For more information, visit www.recodetx.com or contact us at [email protected].
keywords:N/A
$357M
Total Funding
143
Number of Employees
$22.2M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ReCode Therapeutics News
He was replaced by ReCode Therapeutics COO and CFO Julie Eastland. ... on a mission to treat multiple rare diseases with new gene therapies.
BioLabs can house up to 35 companies, and Colossal Biosciences, the company aiming to bring back the woolly mammoth, and ReCode Therapeutics...
With big plans for mRNA-based therapies, companies are racing to apply this ... ReCode Therapeutics announced preclinical data from its...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.3M | 146 | 0% | $201.3M |
#2 | $36.7M | 147 | 13% | N/A |
#3 | $34.2M | 148 | 6% | N/A |
#4 | $15M | 148 | 21% | N/A |
#5 | $21.6M | 154 | 39% | N/A |